Gene57730
ANKRD36B: ankyrin repeat domain 36B
Cite this record
ConductScience Library. ANKRD36B: ankyrin repeat domain 36B. Genes, record 57730. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/57730
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q8N2N9 | Ankyrin repeat domain-containing protein 36B | 1,353 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents22
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260193644 A1 | 2026-07-09 | 22687 | Q8N2N9 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 22687 | Q8N2N9 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 22687 | Q8N2N9 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 5244 | Q8N2N9 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 5246 | Q8N2N9 | Espacenet |
| US 20250084141 A1 | 2025-03-13 | 545 | Q8N2N9 | Espacenet |
| US 12227549 B2 | 2025-02-18 | 545 | Q8N2N9 | Espacenet |
| US 20240398993 A1 | 2024-12-05 | 28449 | Q8N2N9 | Espacenet |
| US 20230026259 A1 | 2023-01-26 | 5244 | Q8N2N9 | Espacenet |
| US 20230026259 A1 | 2023-01-26 | 5246 | Q8N2N9 | Espacenet |
NIH grants354
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ANKRD36B papers | Newest fiscal year |
|---|---|---|---|
| P30CA010815 | Consolidated Basic Cancer Research Program | 7 | 2025 |
| P30CA014520 | UW Comprehensive Cancer Center Support | 3 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 3 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 2 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 2 | 2025 |
| P30CA014089 | University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG) | 2 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 2 | 2025 |
| P30CA016520 | Abramson Cancer Center Support Grant | 2 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 2 | 2025 |
Source NIH's project files
Papers657
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The cancer/testis antigens represent promising targets for the development of new therapies against melanoma. | Pathol Res Pract | 2026 | 42419156 | PubTator, text mining | PubMed |
| Correction: Promiscuous class II-binding SARS-CoV-2-nuc derived vaccine-peptide induced extensive conventional, innate and unconventional T cell responses. | Front Immunol | 2026 | 41766885 | PubTator, text mining | PubMed |
| TWAS atlas 2.0: an updated data resource for transcriptome-wide association studies. | Nucleic Acids Res | 2026 | 41251136 | PubTator, text mining | PubMed |
| mRNA Multipeptide-HLA Class II Immunotherapy for Melanoma. | Cells | 2025 | 41002395 | PubTator, text mining | PubMed |
| Comprehensive analysis of MAGE-A10 in pan-cancer and its validation in gastric cancer. | Sci Rep | 2025 | 40890425 | PubTator, text mining | PubMed |
| Generation and functional analysis of melanoma antigen-specific CD8+ T cells derived from S/MAR vector-transfected human induced pluripotent stem cells. | Int J Cancer | 2025 | 40504044 | PubTator, text mining | PubMed |
| Malignant peripheral nerve sheath tumour with divergent epithelioid differentiation in a cat. | J Comp Pathol | 2024 | 38537328 | PubTator, text mining | PubMed |
| Melanoma Antigen Family A (MAGE A) as Promising Biomarkers and Therapeutic Targets in Bladder Cancer. | Cancers (Basel) | 2024 | 38254738 | PubTator, text mining | PubMed |
| B cells in head and neck squamous cell carcinoma: current opinion and novel therapy. | Cancer Cell Int | 2024 | 38245714 | PubTator, text mining | PubMed |
| Immune checkpoint inhibitors in sarcomas: a systematic review. | Immunooncol Technol | 2023 | 38192615 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/57730
GET https://conductscience.org/api/genes/v1/57730/patents?page=2